- Sanofi- aventis planning to release buccal insulin. Sanofi-aventis has signed a long term agreement with Generex for the manufacture and supply of recombinant human insulin crystals for commercial and clinical trial use.

- Roche’s investigational diabetes drug Taspoglutide moves into phase lll clinical trial. It is the first once weekly glucagon-like peptide-1 (GLP-1) analogue. It is a compound similar to the natural hormone GLP-1 which has a key role in blood sugar regulation